Trial Outcomes & Findings for The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer (NCT NCT03668223)

NCT ID: NCT03668223

Last Updated: 2025-12-05

Results Overview

Pediatric Quality of Life (PedsQL) Cancer Module -This scale was designed to assess pediatric cancer-specific health related quality of life. This is a 27 item scale, with each item rated on a 5-point Likert scale where 0=never and 4=almost always. Higher scores represent better health-related quality of life. Scale range is 0-100.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

195 participants

Primary outcome timeframe

3-months

Results posted on

2025-12-05

Participant Flow

Participant milestones

Participant milestones
Measure
Promoting Resilience in Stress Management (PRISM)
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
Standard psychosocial care
Overall Study
STARTED
99
96
Overall Study
COMPLETED
69
76
Overall Study
NOT COMPLETED
30
20

Reasons for withdrawal

Reasons for withdrawal
Measure
Promoting Resilience in Stress Management (PRISM)
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
Standard psychosocial care
Overall Study
Death
10
5
Overall Study
Lost to Follow-up
12
12
Overall Study
Withdrawal by Subject
8
3

Baseline Characteristics

The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Promoting Resilience in Stress Management (PRISM)
n=99 Participants
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
n=96 Participants
Standard psychosocial care
Total
n=195 Participants
Total of all reporting groups
Age, Continuous
16.51 years
STANDARD_DEVIATION 3.79 • n=37 Participants
16.51 years
STANDARD_DEVIATION 3.99 • n=37 Participants
16.51 years
STANDARD_DEVIATION 3.88 • n=74 Participants
Sex: Female, Male
Female
43 Participants
n=37 Participants
52 Participants
n=37 Participants
95 Participants
n=74 Participants
Sex: Female, Male
Male
56 Participants
n=37 Participants
44 Participants
n=37 Participants
100 Participants
n=74 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
40 Participants
n=37 Participants
37 Participants
n=37 Participants
77 Participants
n=74 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
55 Participants
n=37 Participants
59 Participants
n=37 Participants
114 Participants
n=74 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
n=37 Participants
0 Participants
n=37 Participants
4 Participants
n=74 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=37 Participants
1 Participants
n=37 Participants
2 Participants
n=74 Participants
Race (NIH/OMB)
Asian
5 Participants
n=37 Participants
5 Participants
n=37 Participants
10 Participants
n=74 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=37 Participants
0 Participants
n=37 Participants
0 Participants
n=74 Participants
Race (NIH/OMB)
Black or African American
9 Participants
n=37 Participants
7 Participants
n=37 Participants
16 Participants
n=74 Participants
Race (NIH/OMB)
White
58 Participants
n=37 Participants
62 Participants
n=37 Participants
120 Participants
n=74 Participants
Race (NIH/OMB)
More than one race
22 Participants
n=37 Participants
19 Participants
n=37 Participants
41 Participants
n=74 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=37 Participants
2 Participants
n=37 Participants
6 Participants
n=74 Participants
Region of Enrollment
United States
99 participants
n=37 Participants
96 participants
n=37 Participants
195 participants
n=74 Participants
Pediatric Quality of Life Cancer Module
65.12 units on a scale
STANDARD_DEVIATION 15.78 • n=37 Participants
63.53 units on a scale
STANDARD_DEVIATION 16.16 • n=37 Participants
64.34 units on a scale
STANDARD_DEVIATION 15.95 • n=74 Participants
Connor-Davidson Resilience Scale
27.34 units on a scale
STANDARD_DEVIATION 7.41 • n=37 Participants
29.05 units on a scale
STANDARD_DEVIATION 8.45 • n=37 Participants
28.18 units on a scale
STANDARD_DEVIATION 7.96 • n=74 Participants

PRIMARY outcome

Timeframe: 3-months

Pediatric Quality of Life (PedsQL) Cancer Module -This scale was designed to assess pediatric cancer-specific health related quality of life. This is a 27 item scale, with each item rated on a 5-point Likert scale where 0=never and 4=almost always. Higher scores represent better health-related quality of life. Scale range is 0-100.

Outcome measures

Outcome measures
Measure
Promoting Resilience in Stress Management (PRISM)
n=69 Participants
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
n=76 Participants
Standard psychosocial care
Pediatric Quality of Life Cancer Module
66.89 score on a scale
Standard Deviation 18.07
68.41 score on a scale
Standard Deviation 18.07

SECONDARY outcome

Timeframe: 3-months

The Hospital Anxiety and Depression Scale total score is a 14 items scale on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression. The total score is the sum of all 14 items, ranging from 0-42. Higher scores indicate higher total anxiety/depression.

Outcome measures

Outcome measures
Measure
Promoting Resilience in Stress Management (PRISM)
n=69 Participants
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
n=76 Participants
Standard psychosocial care
Hospital Anxiety and Depression Scale (HADS) Total Score
8.27 score on a scale
Standard Deviation 6.79
9.94 score on a scale
Standard Deviation 7.77

SECONDARY outcome

Timeframe: 3-months

Hope: The Snyder "Hope" Scale measures "the overall perception that one's goals can be met." The instrument scored on an 8-point Likert scale (score range 0-64). Higher scores imply greater levels of hopeful thought patterns.

Outcome measures

Outcome measures
Measure
Promoting Resilience in Stress Management (PRISM)
n=69 Participants
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
n=76 Participants
Standard psychosocial care
Snyder Hope Scale
48.06 score on a scale
Standard Deviation 12.15
46.89 score on a scale
Standard Deviation 14.46

SECONDARY outcome

Timeframe: 3-months

Resilience: The Connor-Davidson Resilience Scale (CD-RISC) measures inherent resiliency. This is a 10-item scale ranging from 0-40 where higher scores reflect greater perceived resilience.

Outcome measures

Outcome measures
Measure
Promoting Resilience in Stress Management (PRISM)
n=69 Participants
Resilience Skills Training Promoting Resilience in Stress Management (PRISM): Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making
Usual Care
n=76 Participants
Standard psychosocial care
Connor Davidson Resilience Scale
28.05 score on a scale
Standard Deviation 7.94
27.45 score on a scale
Standard Deviation 10.16

Adverse Events

Promoting Resilience in Stress Management (PRISM)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 10 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 5 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Abby Rosenberg

Dana Farber Cancer Institute

Phone: 617-632-5286

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place